About Vectura group plc.
Vectura Group Plc. is a leading pharmaceutical company that specializes in formulation science, device technology, and inhaled development expertise. With over 20 years of experience in the industry, Vectura has established itself as a trusted partner for pharmaceutical companies looking to bring DPI, pMDI, and nebulizer medicines to market.
At Vectura, we understand the importance of innovation and collaboration when it comes to developing new medicines. That's why we work closely with our clients to develop customized solutions that meet their specific needs. Our team of experts includes scientists, engineers, and regulatory specialists who are dedicated to delivering high-quality products that improve patient outcomes.
One of our core strengths is our expertise in formulation science. We have developed a range of innovative drug delivery technologies that enable us to create customized formulations for different types of drugs. Our proprietary technologies include GyroHaler®, Lever-operated Inhaler (LOI), and SmartTrack™.
In addition to formulation science, we also specialize in device technology. We have developed a range of inhalation devices that are designed to deliver drugs directly into the lungs where they are needed most. Our devices include dry powder inhalers (DPIs), pressurized metered-dose inhalers (pMDIs), and nebulizers.
Our team also has extensive experience in clinical development and regulatory affairs. We can help guide clients through every stage of the drug development process from preclinical studies through clinical trials and regulatory approval.
At Vectura Group Plc., we are committed to delivering innovative solutions that improve patient outcomes while also providing value for our clients. Whether you're looking for help with formulation science or device technology or need support with clinical development or regulatory affairs, we have the expertise you need to succeed.
In conclusion, if you're looking for a trusted partner who can help you bring your DPIs, pMDIs or nebulizer medicines to market then look no further than Vectura Group Plc. With our specialist capabilities in formulation science, device technology, and inhaled development expertise, we have the knowledge and experience to help you succeed. Contact us today to learn more about how we can help you achieve your goals.